deepeye Medical is dedicated to empowering ophthalmology by enabling deeper insights into treatment data for patients suffering from retinal eye diseases. Founded by medical co-founders with a proven track record, the company globally scales a second-opinion approach using AI technology.

They have developed deepeye4 TPS, the world's first AI assistant to support ophthalmologists with the second reading of every OCT scan, aiding in planning anti-VEGF therapy for neovascular age-related macular degeneration (nAMD) patients. This software is CE marked (Class IIa) under EU Medical Device Regulation, marking a critical milestone in medical AI.

Their mission is to improve the quality of life for patients and doctors by providing experts' AI-driven tools that enable better treatment planning and outcomes. deepeye Medical is committed to transforming retinal therapy practice through artificial intelligence, collaborating with leading institutions like the University Eye Hospital of Munich and partners such as Bayer and Novartis.

They promote a patient need-based "predict & treat" approach, improving therapy adherence and persistence, demonstrated by significant real-world clinical studies.

deepeye Medical offers a dynamic work culture emphasizing immediate responsibility, fast personal growth, and flexible working hours, including remote work options. Their international team, consisting of experts with 17+ years of AI or healthcare experience and diverse nationalities, is motivated by quality, excellence, and diversity, all working together to fight age-related blindness.

Current job opportunities can be found on their career page, supporting roles that enhance healthcare through AI technology.